Service

  • Search and development of new preventive and therapeutic approaches for fighting infections caused by Streptococcus pneumoniae BFU2015-70052-R (2016-2018)

  • Exploring exogenous and endogenous factors as tools for the control of infectious and immune processes BFU2012-36825 (2013-2015)

  • Bioinformatics Integrative Platform for Structure E-based Drug Discovery 2 (BIPEDD2) S2010/BMD-2457 (2012-1015)

  • Ciber de Enfermedades Respiratorias (CIBERES) CB06/06/1102 (since 2008)

  • The Sugar Code: from (bio)chemical concept to clinics (GLYCOPHARM) FP7-ITN-GA:317297 (2012-2016)

  • Dynamic interactive nanosystems (DYNANO) FP7-ITN- GA:289003 (2011-2016)

  • Glycomics by High-throughput Integrated Technologies: Development and validation of complementary and integrated technologies for glycomic analysis of serum in cancer, glycobiomarker discovery, diagnostics and glycotherapeutic monitoring (GlicoHIT) FP7-Health:2010-260600 (2011-2014)



 

 

Current objetives:

  1. Structural, thermodynamic and functional characterization of proteins of biomedical/biotechnology relevance and their complexes with other biomolecules

  2. Study of carbohydrates as biological recognition signals, and of protein-carbohydrate interactions involved in physiological or pathological processes

  3. Search, development and characterization of new antimicrobials against Streptococcus pneumoniae and other respiratory pathogens

  4. Development of new designer microarrays aimed to the structural and functional characterization of systems with different degrees of complexity (from isolated molecules to whole cells)

  5. Study of host-pathogen interactions